Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

על הניסוי

Cystic Fibrosis patients attending with infective exacerbations will be enrolled into the study. The trial is a double blinded, randomised trial with patients randomised to 10,14 or 21 days of antibiotic therapy, comprising of tobramycin and either ceftazidime or meropenem.

צפו ב-NCT01044719 ב-ClinicalTrials.gov ←

קישורים קשורים